resources

Novelix Pharmaceuticals Ltd.

BSE: 536565

Sector: Consumer Services

Industry Group: Retailing

Industry: Pharmacy Retail

76.80-0.3 (-0.39%)

8 Sep, 12:00 AM

Overview Analysis Statements Technicals Forecast Peers Resources

News

Annual Reports and Financial Documents

Novelix Pharmaceuticals Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.

	2013	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026
Annual Reports	FY 2013	FY 2014	FY 2015	FY 2016	FY 2017	FY 2018	FY 2019	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	—
Quarterly Results	—	—	—	—	—	—	—	—	—	—	—	—	Jun Sept Dec	Mar Jun
Conference Calls	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Presentations	—	—	—	—	—	—	—	—	—	—	—	—	—	—

Corporate Announcements and Regulatory Filings

Novelix Pharmaceuticals Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.

General7 Sept 2026
Announcement Under Regulation 30 (LODR)- Letter Of Annual Report & AGM Notice Weblink
Attached.
AGM7 Sept 2026
Shareholders Meeting- Notice Of Annual General Meeting To Be Held On Wednesday, 30Th September, 2026.
Attached.
Reg. 34 (1) Annual Report7 Sept 2026
Reg. 34 (1) Annual Report.
Submission of annual report for the financial year ended March 31, 2026.
AGM31 Aug 2026
Shareholders Meeting AGM On 30Th September, 2026.
Submission of Intimation of AGM Date.
Change in Directorate31 Aug 2026
Announcement under Regulation 30 (LODR)-Change in Directorate
Submission of intimation of change in Designation of Director.
Outcome of Board Meeting29 Aug 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On Saturday, 29Th August, 2026
Submission of outcome of the board meeting.
Board Meeting25 Aug 2026
Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On Saturday, 29Th August, 2026
Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/08/2026 ,inter alia, to consider and approve Submission of Prior ....
General20 Aug 2026
Announcement Under Regulation 30 (LODR) - Lease Deed
Submission of Intimation of Land Lease Deed.
Newspaper Publication16 Aug 2026
Announcement under Regulation 30 (LODR)-Newspaper Publication
Submission of Newspaper Publication of the financial results for the quarter ended 30th June, 2026.
Reg. 32 (1), (3) - Statement of Deviation & Variation13 Aug 2026
Compliances- Statement Of Deviation & Variation
Submission of Statement of Deviation & Variation
Outcome of Board Meeting13 Aug 2026
Board Meeting Outcome for Outcome Of Board Meeting Held On Thursday, 13Th August, 2026 Pursuant To Regulation 30 Of SEBI (Listing Obligation And Disclosure Requirements) Regulations, 2015.
Submission of outcome of the Board meeting.
Board Meeting9 Aug 2026
Board Meeting Intimation for Prior Intimation Of Board Meeting To Be Held On 13Th August, 2026.
Novelix Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/08/2026 ,inter alia, to consider and approve Submission of prior ....
Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 201816 Jul 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Certificate under Reg. 74(5) of SEBI (DP) Regulations, 2018
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201113 Jul 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Vupparapalli Chandrasekhar Reddy & Others
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201113 Jul 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Srinidhi Fine - Chemicals LLP & Others
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201113 Jul 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gattu Gnana Prakash & Others
Code of Conduct under SEBI (PIT) Regulations, 201513 Jul 2026
Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015
Submission of Intimation under regulation 7(2) of SEBI (PIT) Regulations, 2015.
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201113 Jul 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Gattu Gnana Prakash & Others
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 201111 Jul 2026
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011
The Exchange has received the disclosure under Regulation 29(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 for Srinidhi Fine-Chemicals LLP & Narahari Belide
Allotment of Equity Shares10 Jul 2026
Announcement under Regulation 30 (LODR)-Allotment
Submission of intimation of allotment of equity shares.

Frequently Asked Questions

Where can I download the annual report of Novelix Pharmaceuticals Ltd.?

Annual reports of Novelix Pharmaceuticals Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.

Where can I find the quarterly results of Novelix Pharmaceuticals Ltd.?

Quarterly earnings results and presentations of Novelix Pharmaceuticals Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.

Does Novelix Pharmaceuticals Ltd. publish earnings call transcripts?

Earnings call transcripts of Novelix Pharmaceuticals Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.

Where can I find investor presentations of Novelix Pharmaceuticals Ltd.?

Investor presentations and annual day presentations of Novelix Pharmaceuticals Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.

What are the recent corporate announcements of Novelix Pharmaceuticals Ltd.?

Corporate announcements and regulatory filings of Novelix Pharmaceuticals Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.

How do I access the regulatory filings of Novelix Pharmaceuticals Ltd.?

Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Novelix Pharmaceuticals Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.

What is the ISIN of Novelix Pharmaceuticals Ltd.?

The ISIN (International Securities Identification Number) of Novelix Pharmaceuticals Ltd. is INE314I01036. This is the unique identifier used across exchanges and depositories.

On which stock exchange is Novelix Pharmaceuticals Ltd. listed?

Novelix Pharmaceuticals Ltd. is listed on NSE and BSE. The NSE symbol is 536565-BOM and the BSE code is -.

Where can I find the shareholding pattern of Novelix Pharmaceuticals Ltd.?

The quarterly shareholding pattern of Novelix Pharmaceuticals Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.

How current is the data for Novelix Pharmaceuticals Ltd. on Sharpely?

Share price data for Novelix Pharmaceuticals Ltd. is updated as of 8 Sep 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.